×
About 788 results

ALLMedicine™ Lentigo Center

Research & Reviews  267 results

Clinical and histologic features associated with lentigo maligna clearance after imiqui...
https://doi.org/10.1080/09546634.2021.1962001
The Journal of Dermatological Treatment; Kwak R, Joyce C et. al.

Jul 29th, 2021 - Imiquimod cream may be used as non-surgical treatment for lentigo maligna or as adjuvant therapy following excision to decrease risk of recurrence. To evaluate histologic and clinical factors associated with clinical clearance of lentigo maligna t...

Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recomm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280024
Advances in Therapy; Friedman EB, Scolyer RA et. al.

May 29th, 2021 - Most international clinical guidelines recommend 5-10 mm clinical margins for excision of melanoma in situ (MIS). While the evidence supporting this is weak, these guidelines are generally consistent. However, as a result of the high incidence of ...

Risk factors for cardiovascular mortality and melanoma-specific mortality among patient...
https://doi.org/10.1097/CEJ.0000000000000690
European Journal of Cancer Prevention : the Official Jour... Elshanbary AA, Zaazouee MS et. al.

May 20th, 2021 - This study aims to identify the risk factors for cardiovascular mortality in melanoma patients. Data of melanoma patients were obtained from the Surveillance, Epidemiology, and End Results database. We used Person's chi-square test to assess the r...

Lentigo maligna: defining margins and predictors of recurrence utilizing clinical, derm...
https://doi.org/10.1111/jdv.17349
Journal of the European Academy of Dermatology and Venere... Star P, Rawson RV et. al.

May 18th, 2021 - Lentigo maligna (LM) is a subtype of melanoma in situ with poorly defined margins and a high recurrence rate. The biological behaviour of LM appears to differ widely between cases, from biologically indolent to biologically active variants, with s...

Effect of reflectance confocal microscopy compared to dermoscopy in the diagnostic accu...
https://doi.org/10.1111/ijcp.14346
International Journal of Clinical Practice; Nie T, Jiang X et. al.

May 13th, 2021 - Many concerns were raised about the sensitivity and specificity outcome of reflectance confocal microscopy compared to dermoscopy for the diagnosis of lentigo maligna. However, the reported relationships between their sensitivity and specificity w...

see more →

Guidelines  2 results

Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo...
https://doi.org/10.1159/000502470
Dermatology (Basel, Switzerland); Robinson M, Primiero C et. al.

Oct 23rd, 2019 - Lentigo maligna (LM) is a subtype of melanoma in situ that usually occurs in sun-damaged skin and is characterised by an atypical proliferation of melanocytes within the basal epidermis. If left untreated, LM can develop into invasive melanoma, te...

AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a repo...
https://doi.org/10.1111/j.1524-4725.2012.02574.x
Dermatologic Surgery : Official Publication for American ... , et. al.

Sep 11th, 2012 - The appropriate use criteria process synthesizes evidence-based medicine, clinical practice experience, and expert judgment. The American Academy of Dermatology in collaboration with the American College of Mohs Surgery, the American Society for D...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  3 results

Advanced Harmonic Generation Microscopy for Treatment Assessment of Cutaneous Pigmentary Disorder
https://clinicaltrials.gov/ct2/show/NCT03578315

Jul 6th, 2018 - Clinical vision assessment of Solar lentigo or Nevus zygomaticus by numerous counting is known to have poor reliability. Currently, non-invasive histopathological diagnosis and monitoring for Solar lentigo or Nevus zygomaticus become increasingly ...

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face
https://clinicaltrials.gov/ct2/show/NCT02723721

Aug 23rd, 2017 - Non-invasive lentigo maligna (LM) is characterized by an in situ proliferation of melanoma cells, limited to the epidermis. It is found most commonly on the head and neck of elderly persons, with a peak incidence in the seventh or eighth decade. I...

Effect of Topical Imiquimod on Lentigo Maligna
https://clinicaltrials.gov/ct2/show/NCT01161888

Jun 20th, 2012 - The purpose of this study is to determine if topical imiquimod is effective in the pathological complete regression of lentigo maligna.

see more →

News  39 results

Fast Five Quiz: Malignant Melanoma
https://reference.medscape.com/viewarticle/936083_4

Aug 21st, 2020 - Four major clinicopathologic subtypes of primary cutaneous melanoma have been identified, although newer classifications of melanoma include location on chronically sun-exposed vs intermittently or non–sun-exposed skin and incorporate the presence...

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.medscape.com/viewarticle/935774

Aug 17th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

Melanoma Clinical Practice Guidelines (2020)
https://reference.medscape.com/viewarticle/924512

Jan 31st, 2020 - Consensus-based interdisciplinary guidelines on the diagnosis and treatment of melanoma were released in January 2020 by the European Dermatology Forum, the European Association of Dermato-Oncology, and the European Organization for Research and T...

Expert spotlights telltale clinical signs of xeroderma pigmentosum
https://www.mdedge.com/pediatrics/article/207921/pediatrics/expert-spotlights-telltale-clinical-signs-xeroderma-pigmentosum?channel=39313
Doug Brunk

Sep 10th, 2019 - AUSTIN, TEX. – If a child presents with acute photosensitivity at a young age, onset of freckling before the age of 2 years, and severe sun damage of the lips and eyes, think xeroderma pigmentosum (XP), a rare autosomal recessive disorder.

Five rules for evaluating melanonychia
https://www.mdedge.com/dermatology/article/202117/hair-nails/five-rules-evaluating-melanonychia/page/0/1?channel=244

Jun 3rd, 2019 - Rule #4: Don’t wimp out when a biopsy is warranted Many dermatologists hem and haw about doing a biopsy for a concerning lesion on the nail, when they wouldn’t hesitate to biopsy a similarly suspicious lesion on the face. But it’s essential to bio.

see more →

Patient Education  2 results see all →